Since hepatic Irs2 mRNA levels have been reported to be actually lower in NAFLD patients [165], downregulated Irs2 might be involved in the pathogenesis of hepatic insulin resistance. This evidence concerns the gene IRS2 and metabolic dysfunction-associated steatotic liver disease.